Long Term Acute Care Market Size, Share to grow to around USD 4.6 trillion by 2028
The study covers the global long term acute care market’s size, drivers, restraints/challenges, and the influence they have on the demands during the projected period. In addition, the study analyses potential prospects in the market. According to Zion Market Research, The global long term acute care market size was valued at around USD 2.8 trillion in 2021 and is anticipated to increase to around USD 4.6 trillion by 2028 with a CAGR of roughly 6.85% between 2022 and 2028. The Global Long Term Acute Care Market Size is dominated by players like Fresenius Medical Care AG & Co. KGaA, TH Medical (Tenet Healthcare Corporation), Ascension, Asklepios Kliniken GmbH& Co. KGaA, Ramsay Health Care, IHH Healthcare Berhad, Universal Health Services, Inc., Mediclinic International, Community Health Systems, Inc., Lifepoint Health, Inc., and Ardent Health Services.
Get a FREE PDF Report Sample Copy: https://www.zionmarketresearch.com/sample/global-long-term-acute-care-market
The global long term acute care market is segmented as follows:
By Facility Type
By Medical Care
By Service
领英推荐
Recent Developments:
Global Long Term Acute Care Market: Growth Drivers
Increasing patient demand for LTAC will drive market growth.
The global long term acute care market size is anticipated to expand significantly due to the dramatic rise in the number of people suffering from acute diseases and requiring substantial medical treatment. Chronic kidney disease (CKD) is one of the leading reasons for lengthier hospital admissions where patients require continual medical monitoring, and the number of patients suffering from CKD has exploded in recent years.
In the United States, nearly 15% of adults will be afflicted with CKD by 2022, which is more than 1 in 7 people. CKD is an exceedingly common medical ailment that affects about 10% of the global population, and if left untreated, it can have devastating effects on a patient's health. The increase in cardiovascular illnesses (CVDs) such as coronary heart disease, peripheral arterial disease, and others contributes to the market's expansion. The disease's causes range from hereditary to lifestyle and dietary factors. According to the World Health Organization (WHO), more than 17,9 persons died from CVDs in 2019, accounting for around 32 percent% of the worldwide mortality toll.
Read Other Reports: